Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 1];10(2):s753. Available from: https://skin.dermsquared.com/skin/article/view/4111